"Learn simple strategies to identify Multibaggers & Trade Nifty Options with confidence"
Srei Infra share price recently made its 52 weeks high on 4th July 2016, and has been trading near it as on Tuesday, Srei Equipment , a wholly owned subsidiary of SREI Infrastructure Finance, said that Brickwork Ratings has upgraded its rating to BWR 'AA+' with stable outlook from BWR "AA" for its non-convertible debentures (NCDs) aggregating to Rs 2,130 crore. The rating shows that the instruments are considered to have a high degree of safety concerning timely servi
Meininger Hotels that are owned by Cox & Kings, will open a hotel close to Leipzig's main station at the beginning of 2017. The Accor Group's former ibis Hotel will be converted according to the standards of Meininger and will ultimately have 404 beds available in 126 rooms. The hotel is located in the centre of Leipzig and is the ideal starting point for exploring the city. Numerous places of interest, such as the opera, the Gewandhaus concert hall and the publishing district are pretty close to the
Cadila share price rose 3.29% as the healthcare leader Cadila or Zydus Cadila has entered into a non-exclusive, royalty-free agreement with Medicines Patent Pool (MPP) for the universal production of Bristol-Myers Squibb's daclatasvir, a novel direct-acting antiviral (DAA). The medicine is proven to help cure multiple genotypes of the Hepatitis C Virus (HCV). The company said that the agreement sub-licenses Zydus to produce and sell daclatasvir in 112 low and middle-income countries. <a href="htt
Today, Anil Ambani-led Reliance Communications announced the appointment of Juergen Hase as the Group CEO for its IoT Business. The Reliance Group has drawn up an extensive strategy, with an emphasis on initially leveraging its domain prowess across existing business sections in telecommunications, power and utilities, financial services, health care, and road and metro rail transportation, and its over 250 million customer base, to drive speeded up growth in the IoT space. Reliance Communications has alre
The construction arm of L&T has won orders worth Rs. 3598 crores across various business segments. It Includes a major order to construct a barrage in Telangana. LT share price has been trading at Rs. 1,564.45 when the announcement was made. Heavy Civil Infrastructure Business: Irrigation and Command Area Development Department (I&CAD), Government of Telangana, gran
ADLABS share price rises almost 4% as the announcement is made about Govt. Of Maharashtra giving Walkwater Properties private Limited (WPPL) the locational clearance for the special township. WPPL is a wholly owned subsidiary of ADLABS Entertainment Limited. The township will be developed on part of the surplus land owned by WPPL adjacent to IMAGICA. The approvals have come under the Special Township Policy 2006/2014 of the Government of Maharashtra. WPPL holds approx. 138 acres of land, of which the approval is granted for 88 acres
SaaS-based startup DSYH, Don't Scratch Your Head, has received $250K seed funding from Venture Catalysts (Vcats), a Mumbai-based seed investment and innovation platform. DSYH was accelerated at Reliance Industries Limited's GenNext Hub and powered by Microsoft Accelerator India. Reliance has helped DYSH in growing and entering in to the global market and hence have played a good hand in its success.
Nifty is expected to stay in a trading range going forward. Smallcap has achieved its monthly target of 5972.Stock Market Today by Shailesh Saraf.
After contributing in different states with the exquisite jewellery collection satisfying the tastes of jewellery connoisseurs all around the country, PC Jeweller sets another significant achievement in its success story with the opening of a new showroom in Bhubaneswar which is also its 63rd in all. PC Jeweller share price
Today, Alembic pharma announced that the company has acquired the tentative approval from the US Food and Drug Administration (USFDA) for its ANDA, i.e, Abbreviated New Drug Application for 40 mg and 80 mg febuxostat tablets. The approved ANDA is therapeutically equal to the Reference Listed Drug Product, or RLD, of USA's Takeda Pharma's 40 mg and 80 mg of Uloric tablets. Febuxostat is indicated for the chronic management of hyperuricemia in patients with gout.
